The vitamin D pathway is a dynamic system, and its functional role in bone health and other diseases is the subject of intense research. Associations of vitamin D deficiency with a wide spectrum of disease states have drawn attention from the scientific community and increasing awareness of the general population. Despite vitamin D deficiency being a global public health concern, the approach through improving vitamin D status by supplementation, dietary intake and increased sunlight exposure, has resulted in mixed outcomes 6 , where a greater association is observed between 1,25(OH) 2 D and 25(OH)D, dependent upon the severity of the renal impairment. The lack of a direct relationship, despite their close proximity in the metabolic pathway, is due to the tight regulation of the hydroxylation enzymes
The vitamin D pathway is a dynamic system, and its functional role in bone health and other diseases is the subject of intense research. Associations of vitamin D deficiency with a wide spectrum of disease states have drawn attention from the scientific community and increasing awareness of the general population. Despite vitamin D deficiency being a global public health concern, the approach through improving vitamin D status by supplementation, dietary intake and increased sunlight exposure, has resulted in mixed outcomes [1] [2] [3] . The contradictory evidence has prompted studies on the metabolites of vitamin D. The most abundant metabolite in circulation is 25-hydroxyvitamin D (25(OH)D), which exists in two major forms: 25-hydroxycholecalciferol (25(OH)D3) and 25-hydroxyergocalciferol (25(OH)D2). Measurement of serum total 25(OH)D (D3 + D2) is the barometer of vitamin D status; concentrations ≤30 nmol/L and between 30-50 nmol/L are defined as deficient and insufficient, respectively by the U.S Institute of Medicine (IOM) 4 and the UK National Osteoporosis Society (NOS) 5 . 1,25-dihydroxyvitamin D (1,25(OH) 2 D) is synthesised by the hydroxylation of 25(OH)D through the actions of 1α-hydroxylase produced in the renal tubules. 1,25(OH) 2 D is the most biologically active form of vitamin D and circulates in pmol/L concentration; it controls intestinal absorption of calcium and phosphate, stimulates osteoclast activity, and helps regulate the release of parathyroid hormone (PTH). Although 1,25(OH) 2 D is derived from 25(OH)D, there is no direct correlation in serum concentrations between the two vitamin D metabolites except in patients with chronic kidney disease (CKD) 6 , where a greater association is observed between 1,25(OH) 2 D and 25(OH)D, dependent upon the severity of the renal impairment. The lack of a direct relationship, despite their close proximity in the metabolic pathway, is due to the tight regulation of the hydroxylation enzymes expressed by the actions of CYP27B1 and CYP24A1. CYP24A1 produces 24- 8, 9 . The use of VMR in the population can provide an assessment of the vitamin D catabolic status; thus allowing a targeted approach to vitamin D supplementation 10 .
In this report, we describe a novel approach to the interpretation of serum 25(OH)D and 1,25(OH) 2 D concentrations that incorporates 24,25(OH) 2 D values. Using data from a large cohort of young healthy adults as our reference population, we report the intricate relationships between active and catabolic forms of vitamin D metabolites, and the influence on PTH.
Results
Results from 940 participants were included in the data analysis. Statistical analyses on 25(OH)D and 24,25(OH) 2 D were performed on the respective total (sum of D3 + D2) values, the distributions were untrimmed and no outlier was removed. Summary of the distribution of biochemical profile is shown in Table 1 . 25(OH)D2 was found in 57.8% of the subjects, mean (range) of 4.2 nmol/L (0.6-29.1). 24,25(OH) 2 D2 was found in 0.4% of the subjects, mean (range) 1.5 nmol/L (1.2-1.8).
24,25(OH) 2 D and 25(OH)D.
The mean concentration of 24,25(OH) 2 D was on average 9.5-fold lower than 25(OH)D. Linear regression analysis (Fig. 1a) showed a directly proportional relationship between 24,25(OH) 2 (Fig. 1b) . This finding is consistent with published studies; 1,25(OH) 2 D is able to directly inhibit the expression of 1α-hydroxylase, and indirectly inhibit by suppressing PTH and stimulating FGF23 production 11, 12 . This negative feedback system provides an essential safeguard mechanism against hypercalcaemia, hence 1,25(OH) 2 . In our previous publication 7 , we described a case of biallelic CYP24A1 mutation in a patient presenting with hypercalcaemia, elevated serum 1,25(OH) 2 18, 19 . More recently there is increasing evidence supporting physiological functions of 24,25(OH) 2 D on bone and cartilage [20] [21] [22] in promoting fracture healing, and protection against cartilage damage. The existence of a 24,25(OH) 2 D-specific nuclear or membrane receptor has been reported 23 , but its function has yet to be elucidated. Given that CYP24A1, the enzyme responsible for the production of 24,25(OH) 2 D, is present in most tissues with VDR, understanding the mechanisms controlling the production of 24,25(OH) 2 D relative to other vitamin D metabolites may have significance beyond vitamin D catabolism, potentially shaping vitamin D supplementation strategies.
Mapping the circannual rhythms of vitamin D metabolites and VMRs is an important component of this study. We have published reports on longitudinal studies (Macdonald et al.) 15, 16, 24 , decribing the changes in serum 25(OH)D and 24,25(OH) 2 D throughout a year in vitamin D supplemented or non-supplemented subjects. In the VICtORy (Vitamin D and CardiOvascularRisk) 15 and VICtORy RECALL 16 randomised controlled studies performed using a group of postmenopausal women residing in the northeast of UK, the placebo group showed a two-fold increase in serum 25(OH)D in peak summer months (July-August), compared to the nadir in late winter months (January-March). Our younger cohort of healthy individuals in this study showed similar trends; 24,25(OH) 2 One strength of our data is the chosen cohort; with participants attending blood sampling visits at strictly controlled time intervals and that the vitamin D metabolites were measured using gold-standard methodologies. The participants are well-defined, largely from a similar social-economic background, and exposed to the same level of fitness training, diet, and frequency of outdoor activities. The relative homogeneity of the subjects of our study population in combination with our inclusion criteria allowed us to confidently form a reference population and identify important changes in analytes. The limitations are that our findings are observational and based on baseline sampling at the start of training. Also, our cohort represents young adults of Caucasian extraction (92.9%), and cannot be extrapolated to the wider population of mixed ethnicity. The predictive threshold values were established based on the equivalent vitamin D status as described by IOM, and not based on our own data as the study was not randomly controlled. We did not measure vitamin D binding protein (VDBP) and free www.nature.com/scientificreports www.nature.com/scientificreports/ 25(OH)D due to the ethnic homogeneity of our population, and we did not exclude factors that may influence VDBP levels (e.g. oral contraceptive use in female recruits). We also acknowledge the use of VMR in reverse (i.e. 24,25(OH) 2 D:25(OH)D -as described in 25 ) can be an alternative approach to express the relationship. Lastly, the sample data used in the current study is a subset of the Army cohort used to establish the reference intervals of serum 24,25(OH) 2 D 7 . Whilst there is a degree of overlap, the overall content of this report, analytical approaches and conclusions described are independent of the previous report.
In conclusion, the present analysis characterises the absolute and relative concentrations of the active and catabolic form of vitamin D metabolites in a well-defined young, healthy and physically fit population. The use of VMRs provides insight into the metabolic pathway and the variations exhibited throughout the year. We propose a three-dimensional model incorporating 1,25(OH) 2 Table 3 . In total, 2252 new British Army recruits at the start of phase one training volunteered for the study. Written informed consent was obtained from all study participants, and each required to complete a detailed health questionnaire, including medical history and the use of supplements. All recruits undertook physical and cognitive testing, and a detailed medical examination prior to joining the army. The British Army entry requirements restrict individuals with chronic medical conditions; therefore, our study population represents a medically screened, disease-free, and physically fit population. In the analysis, we excluded individuals who reported the use of calcium and vitamin D supplements (including multivitamins and cod liver oil), and excluded participants who reported injury and illness prior to recruitment; conditions such as being underweight, eating disorders, or those with a history of bone fracture. 940 participants were included in the final statistical analyses. The majority of participants were from Caucasian population (92.9%), with a minority from a diverse ethnicity (Asian 1.6%, Black 1.7%, Chinese 0.1%, mixed 3%, others 0.7%).
sample collection. Blood samples were collected during the period of June 2014 and March 2016. Venous blood samples were obtained from the participants at the start of 14-week long basic military training. Sample collections were scheduled on a monthly basis to balance the seasonal variations. Each intake comprised, on average (range), 86 (43-120) participants. Blood samples were collected into serum gel separator tube and EDTA plasma container (BD Vacutainer). Samples were centrifuged immediately after collection at 3,000 × g for 10 minutes. Plasma/serum layers were aliquoted into a separate polystyrene tube and stored at −20 °C until analysis. All samples were anonymised to the researchers at the point of access. 
LC-MS/MS measurements of serum 25(OH)D and 24,25(OH) 2 D.
Liquid chromatography tandem mass spectrometry (LC-MS/MS) was performed as described 7, [26] [27] [28] . The method quantified 25(OH)D3, 25(OH) D2, 24,25(OH) 2 D3 and 24,25(OH) 2 D2 simultaneously from a single injection. 25(OH)D3 and 25(OH)D2 were calibrated using commercial standards (Chromsystems, München, Germany) traceable to standard reference material SRM972a from the National Institute of Science and Technology (NIST) 25, 29 , and showed linearity between 0-200 nmol/L. The inter/intra-assay coefficient of variation (CV) was ≤9%, the lower limit of quantification (LLoQ) of 0.1 nmol/L. The assay showed <8% accuracy bias against NIST reference method on the Vitamin D external quality assessment (DEQAS) scheme. 24,25(OH) 2 D3 and 24,25(OH) 2 D2 were calibrated using in-house spiked standards traceable to NIST SRM972a. The assay is linear between 0-25 nmol/L; inter/ intra-assay CV was ≤11%, LLoQ of 0. Table 3 . Baseline characteristics of the subjects included in the study. *Data shown in mean ± SD otherwise stated.
www.nature.com/scientificreports www.nature.com/scientificreports/ 94 ± 2%. On the Vitamin D external quality assessment (DEQAS) scheme, the assay showed ≤8.5% bias against method-specific mean and ≤9.1% bias against all method mean. Biochemical analysis. Intact PTH and albumin-adjusted calcium (ACa) were analysed on the COBAS ® (Roche Diagnostics, Mannheim, Germany) platform. PTH in EDTA plasma was measured using electrochemiluminescence immunoassay (ECLIA), the inter-assay CV was ≤3.8% across the analytical range of 1.2-5000 pg/mL. Total calcium and albumin were measured based on spectrophotometric methods. The inter-assay CV for Ca was ≤1.6%, albumin was ≤1.1%. ACa value is calculated using the equation statistical analysis. Descriptive statistics, scatterplots, ROC and LOWESS curves were constructed and analysed by Statistical Package for the Social Science (SPSS) version 22.0.0.1 (IBM, New York, USA) and GraphPad Prism 7 (GraphPad, San Diego, CA, USA). Univariate and multivariable linear regression analyses and one-way ANOVA were used to estimate associations. LOWESS curve fitting was used to explore nonlinear relationships between variables. Kruskal-Wallis independent analysis and Spearman's rho were used to establish associations in non-parametric variables. Statistical significance was defined as p < 0.05. Frequency distribution histograms of the data were visually examined and checked for transcriptional and pre/post analytical errors before exclusion for statistical analysis. Confidence interval (CI) was established at 95% of the population. Circannual rhythm analysis was performed by population-mean cosinor analysis, based on cosinor-fitting equation y x MESOR Amplitude cos(Frequency( ) acrophase) = + × + . Midline estimate statistic of rhythm (MESOR), defined as the rhythm-adjusted mean value. Acrophase is the difference (time) between MESOR and peak value in the cosine curve.
